• March 10, 2025

Alts.co – Sen-Jam Pharmaceutical Follow up

Dear Alts.co member,


Thank you for your interest in Sen-Jam Pharmaceutical.  

I’ve attached our Investor Deck and our Market Analysis & Valuation (Executive Summary) for our 2 lead assets, developed by Destum Partners.  We recently engaged Destum to seek licensing, co-development, and M&A partners for these lead assets.

Let me know if you would like to be added  to our Investor Relations Letter to keep you updated on our progress.  Here is a snapshot of our recent activities, 

Thank you again for your interest—we would be thrilled to have you join us in our mission to revolutionize healthcare!  

Let me know if you have any questions or you can join our mission here, https://wefunder.com/senjam.  Our campaign ends on April 7th.

Jim


Jim Iversen
CEO
Sen-Jam Pharmaceutical
223 Wall St., #130
Huntington, NY 11743
201-400-8083
jiversen@sen-jam.com
sen-jam.com
Linkedin: linkedin.com/in/jimiversen
Learn about our Reg CF offering on Wefunder